120-DAY PMA REVIEW PROCESS FOR WELL-UNDERSTOOD PRODUCTS TO BE TESTED FOR IN VITRO DIAGNOSTICS; PMA SUPPLEMENT DRAFT GUIDANCE DOCUMENT NEARING COMPLETION
This article was originally published in The Gray Sheet
Executive SummaryAn FDA proposal for a 120-day fast-track review of premarket approval applications for well-understood products is expected to be sent to manufacturers for comment by the end of November.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.